Literature DB >> 30037355

Randomized controlled trial of a self-administered five-day antiseptic bundle versus usual disinfectant soap showers for preoperative eradication of Staphylococcus aureus colonization.

Susan E Kline1, James D Neaton2, Ruth Lynfield3, Patricia Ferrieri4, Shalini Kulasingam5, Kayleigh Dittes1, Anita Glennen3, Selina Jawahir3, Alexander Kaizer6, Jeremiah Menk6, James R Johnson1.   

Abstract

OBJECTIVE: To determine the efficacy in eradicating Staphylococcus aureus (SA) carriage of a 5-day preoperative decolonization bundle compared to 2 disinfectant soap showers, with both regimens self-administered at home.
DESIGN: Open label, single-center, randomized clinical trial.
SETTING: Ambulatory orthopedic, urologic, neurologic, colorectal, cardiovascular, and general surgery clinics at a tertiary-care referral center in the United States.ParticipantsPatients at the University of Minnesota Medical Center planning to have elective surgery and not on antibiotics.
METHODS: Consenting participants were screened for SA colonization using nasal, throat, axillary, and perianal swab cultures. Carriers of SA were randomized, stratified by methicillin resistance status, to a decolonization bundle group (5 days of nasal mupirocin, chlorhexidine gluconate [CHG] bathing, and CHG mouthwash) or control group (2 preoperative showers with antiseptic soap). Colonization status was reassessed preoperatively. The primary endpoint was absence of SA at all 4 screened body sites.
RESULTS: Of 427 participants screened between August 31, 2011, and August 9, 2016, 127 participants (29.7%) were SA carriers. Of these, 121 were randomized and 110 were eligible for efficacy analysis (57 decolonization bundle group, 53 control group). Overall, 90% of evaluable participants had methicillin-susceptible SA strains. Eradication of SA at all body sites was achieved for 41 of 57 participants (71.9%) in the decolonization bundle group and for 13 of 53 participants (24.5%) in the control group, a difference of 47.4% (95% confidence interval [CI], 29.1%-65.7%; P<.0001).
CONCLUSION: An outpatient preoperative antiseptic decolonization bundle aimed at 4 body sites was significantly more effective in eradicating SA than the usual disinfectant showers (ie, the control).Trial RegistrationClinicalTrials.gov identifier: NCT02182115.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30037355     DOI: 10.1017/ice.2018.151

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  5 in total

1.  What is the most cost-effective strategy for nasal screening and Staphylococcus aureus decolonization in patients undergoing total hip arthroplasty?

Authors:  Hisahiro Tonotsuka; Hajime Sugiyama; Ayano Amagami; Keigo Yonemoto; Ryuichi Sato; Mitsuru Saito
Journal:  BMC Musculoskelet Disord       Date:  2021-02-01       Impact factor: 2.362

2.  Application of 233 nm far-UVC LEDs for eradication of MRSA and MSSA and risk assessment on skin models.

Authors:  Paula Zwicker; Johannes Schleusener; Silke B Lohan; Loris Busch; Claudia Sicher; Sven Einfeldt; Michael Kneissl; Anja A Kühl; Cornelia M Keck; Christian Witzel; Axel Kramer; Martina C Meinke
Journal:  Sci Rep       Date:  2022-02-16       Impact factor: 4.379

3.  An evaluation of risk factors for Staphylococcus aureus colonization in a pre-surgical population.

Authors:  Serin Edwin Erayil; Elise Palzer; Susan Kline
Journal:  Access Microbiol       Date:  2022-01-12

4.  Preventing Infection in Implant-based Breast Reconstruction: Evaluating the Evidence for Common Practices and Standardized Protocols.

Authors:  Nusaiba F Baker; Owen Brown; Alexandra M Hart; Dora Danko; Christopher M Stewart; Peter W Thompson
Journal:  Plast Reconstr Surg Glob Open       Date:  2022-03-22

5.  Modeling Interventions to Reduce the Spread of Multidrug-Resistant Organisms Between Health Care Facilities in a Region.

Authors:  Sarah M Bartsch; Kim F Wong; Leslie E Mueller; Gabrielle M Gussin; James A McKinnell; Thomas Tjoa; Patrick T Wedlock; Jiayi He; Justin Chang; Shruti K Gohil; Loren G Miller; Susan S Huang; Bruce Y Lee
Journal:  JAMA Netw Open       Date:  2021-08-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.